ZA859526B - Pharmaceutically active derivatives of tryptophan and pharmaceutical compositions containing them - Google Patents

Pharmaceutically active derivatives of tryptophan and pharmaceutical compositions containing them

Info

Publication number
ZA859526B
ZA859526B ZA859526A ZA859526A ZA859526B ZA 859526 B ZA859526 B ZA 859526B ZA 859526 A ZA859526 A ZA 859526A ZA 859526 A ZA859526 A ZA 859526A ZA 859526 B ZA859526 B ZA 859526B
Authority
ZA
South Africa
Prior art keywords
group
substituted
tryptophan
pharmaceutical compositions
compositions containing
Prior art date
Application number
ZA859526A
Other languages
English (en)
Inventor
Francesco Makovec
Rolando Chiste
Luigi Rovati
Original Assignee
Rotta Research Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Lab filed Critical Rotta Research Lab
Publication of ZA859526B publication Critical patent/ZA859526B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA859526A 1984-12-12 1985-12-12 Pharmaceutically active derivatives of tryptophan and pharmaceutical compositions containing them ZA859526B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT68241/84A IT1179866B (it) 1984-12-12 1984-12-12 Derivati del triptofano farmaceuticamente attivi e composizioni farmaceutiche che li contengono

Publications (1)

Publication Number Publication Date
ZA859526B true ZA859526B (en) 1986-08-27

Family

ID=11308641

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA859526A ZA859526B (en) 1984-12-12 1985-12-12 Pharmaceutically active derivatives of tryptophan and pharmaceutical compositions containing them

Country Status (14)

Country Link
US (1) US4870097A (it)
EP (1) EP0237522B1 (it)
JP (1) JPS62501292A (it)
AT (1) ATE85976T1 (it)
AU (1) AU589938B2 (it)
CA (1) CA1256441A (it)
DE (1) DE3587122T2 (it)
DK (1) DK168564B1 (it)
ES (1) ES8706630A1 (it)
IE (1) IE58502B1 (it)
IT (1) IT1179866B (it)
PT (1) PT81674B (it)
WO (1) WO1986003489A1 (it)
ZA (1) ZA859526B (it)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814463A (en) * 1985-12-31 1989-03-21 Biomeasure, Inc. CCK antagonists
US5089638A (en) * 1986-06-16 1992-02-18 Merck & Co., Inc. Amino acid analogs as CCK-antagonists
US4880938A (en) * 1986-06-16 1989-11-14 Merck & Co., Inc. Amino acid analogs
SE8901149D0 (sv) * 1989-04-03 1989-04-03 Pharmacia Ab Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat
US5360814A (en) * 1991-02-28 1994-11-01 Merrell Dow Pharmaceuticals Inc. NMDA antagonists
US5484814A (en) * 1991-02-28 1996-01-16 Merrell Dow Pharmaceuticals Inc. NMDA antagonists
ES2122098T3 (es) * 1991-02-28 1998-12-16 Merrell Pharma Inc Antagonistas del nmda.
US20030199523A1 (en) * 2002-02-28 2003-10-23 Snutch Terrance P. Heterocyclic calcium in channel blockers
EP2311479B1 (en) 2002-09-20 2014-07-23 The Trustees of The University of Pennsylvania Compstatin analogs with improved activity
US8168584B2 (en) 2005-10-08 2012-05-01 Potentia Pharmaceuticals, Inc. Methods of treating age-related macular degeneration by compstatin and analogs thereof
EP1951279B1 (en) 2005-10-08 2017-04-12 Apellis Pharmaceuticals, Inc. Compstatin and analogs thereof for eye disorders
ES2390828T3 (es) 2005-11-28 2012-11-16 The Trustees Of The University Of Pennsylvania Análogos potentes de la compstatina
HUE026001T2 (en) 2007-02-05 2016-04-28 Apellis Pharmaceuticals Inc Compstatin analogues for use in the treatment of the inflammatory condition of the respiratory system
PT2424557T (pt) 2009-05-01 2018-02-05 Univ Pennsylvania Compstatina modificada com estrutura peptídica e modificações no terminal c
US20140113874A1 (en) 2010-09-23 2014-04-24 The Trustees Of The University Of Pennsylvania Modified Compstatin With Improved Stability And Binding Properties
JP2014503592A (ja) 2011-01-26 2014-02-13 ニコ ワールドワイド，インコーポレイテッド 片頭痛の療法
JP6522337B2 (ja) 2011-05-11 2019-05-29 アペリス・ファーマシューティカルズ・インコーポレイテッドＡｐｅｌｌｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． 細胞反応性、長時間作用型または標的化コンプスタチン類似体およびその使用
JP6618682B2 (ja) 2011-06-22 2019-12-11 アペリス・ファーマシューティカルズ・インコーポレイテッドＡｐｅｌｌｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． 補体阻害剤による慢性障害の治療方法
CN110229216B (zh) 2011-09-07 2023-06-16 宾夕法尼亚州大学理事会 具有改善的药代动力学性质的坎普他汀类肽
SI3660033T1 (sl) 2012-11-15 2021-09-30 Apellis Pharmaceuticals, Inc. Analogi kompstatina z dolgotrajnim delovanjem in sorodni sestavki in postopki
WO2014152391A1 (en) 2013-03-15 2014-09-25 Apellis Pharmaceuticals, Inc. Cell-penetrating compstatin analogs and uses thereof
US10213476B2 (en) 2014-03-17 2019-02-26 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved potency and pharmacokinetic properties
CA3001128A1 (en) 2015-10-07 2017-04-13 Apellis Pharmaceuticals, Inc. Use of long-acting compstatin analog for treating a complement-mediated eye disorder
JP2018534303A (ja) * 2015-11-12 2018-11-22 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク ポリミキシン系抗生物質に対する耐性グラム陰性細菌感染を標的にする合理的薬物設計
KR20190139931A (ko) 2017-04-07 2019-12-18 아펠리스 파마슈티컬스 인코포레이티드 투여 요법 및 관련 조성물 및 방법
CA3061340A1 (en) 2017-04-25 2018-11-01 Temple Otorongo Llc Pharmaceutical composition comprising tryptophan and phyllokinin derivative for use in treating psychiatric and psychological conditions
MX2020010520A (es) 2018-04-06 2021-01-15 Univ Pennsylvania Analogos de compstatina con mayor solubilidad y mejores propiedades farmacocineticas.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1055518B (it) * 1971-05-18 1982-01-11 Rotta Research Lab Derivatives del triptofano
US4482567A (en) * 1982-10-07 1984-11-13 Research Foundation For Mental Hygiene, Inc. N-hexanoyl to n-heptadecanoyl 5-hydroxy tryptophan-5-hydroxytryptophanamides and use as analgesics

Also Published As

Publication number Publication date
EP0237522B1 (en) 1993-02-24
IT8468241A1 (it) 1986-06-12
IT8468241A0 (it) 1984-12-12
DE3587122T2 (de) 1993-07-15
DK381486D0 (da) 1986-08-11
WO1986003489A1 (en) 1986-06-19
IE853029L (en) 1986-06-12
DK168564B1 (da) 1994-04-25
IT1179866B (it) 1987-09-16
ATE85976T1 (de) 1993-03-15
ES8706630A1 (es) 1987-06-01
ES549822A0 (es) 1987-06-01
AU5209986A (en) 1986-07-01
PT81674A (en) 1986-01-01
EP0237522A1 (en) 1987-09-23
DE3587122D1 (de) 1993-04-01
US4870097A (en) 1989-09-26
DK381486A (da) 1986-08-11
CA1256441A (en) 1989-06-27
PT81674B (pt) 1987-10-20
JPS62501292A (ja) 1987-05-21
IE58502B1 (en) 1993-10-06
AU589938B2 (en) 1989-10-26

Similar Documents

Publication Publication Date Title
ZA859526B (en) Pharmaceutically active derivatives of tryptophan and pharmaceutical compositions containing them
ATE8874T1 (de) Therapeutisch nuetzliche 1-alkyl-2-amino-tetralin- derivate.
AU611113B2 (en) Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds
IL79910A (en) 5,7-dihydro-6-(thi)oxopyrrolo(2,3-f)benzimidazole,-benzothiazole and-benzoxazoles,6-imines thereof,their preparation and pharmaceutical compositions containing them
PT77666B (fr) Procede de preparation de nouveaux derives de la nitrosouree
GB2152508A (en) Pyrimidine derivatives
ZA858030B (en) Thiadiazole derivatives active on the central nervous system,process for their preparation and pharmaceutical compositions in which they are present
MX11959A (es) Procedimiento de preparacion de nuevos derivados de 1-aril-sulfonil-1, 5-dihidro-2h-pirrol-2-ona y producto obtenido.
DE3361670D1 (en) N-substituted imidazole derivatives, their preparation, pharmaceutical compositions containing them and their use
MX11977A (es) Derivados de 1-bencil-2-oxo-5-alcoxi-pirrolidina y procedimiento para su preparacion.
IT1254745B (it) Ciclofosfazeni contenenti gruppi di acido acetil salicilico, procedimento di preparazione ed utilizzazione